KTTA Financials
Pasithea Therapeutics Corp - Financial statements & key metrics
Stock Price
$0.74
Market Cap
$18.36M
EPS
$-2.91
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$0.00
Gross Profit
$-662585.00
Operating Income
$-20.86M
Net Income
$-20.43M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$60.24M
Total Liabilities
$5.02M
Shareholders Equity
$55.22M
Cash & Equivalents
$55.16M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-15.21B
CapEx
$0
Free Cash Flow
$-15.21B
Profitability Metrics
Gross Margin
-0.5%
ROE
-0.6%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is KTTA revenue?
KTTA's most recent quarterly revenue was $0.00. Annual revenue can be calculated by summing the four most recent quarters.
Is KTTA profitable?
KTTA reported a loss of $20.43M in the most recent quarter.
What is KTTA market cap?
KTTA has a market capitalization of $18.36M, making it a small-cap stock.
Does KTTA have debt?
View KTTA's balance sheet for debt information.
What is KTTA cash flow?
KTTA's most recent quarterly free cash flow was $-15.21B.